Opinions
Robert McWhirter
Sernova Corp.
SVA-X
BUY
Apr 12, 2021
They produce a credit card-size device beneath the skin to produce to produce insulin and regulate body sugar levels. This helps diabetics and those with thyroid conditions. Testing results have been positive. He's optimistic about this.
$1.570
Stock price when the opinion was issued
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
BUY
Disclosure: He's helped with 2-3 of their financings recently. They make a credit-card sized pouch inserted under the skin that produces insulin to reduce extreme high or low insulin levels. That pouch can be used for many other applications in the future. Results are coming soon. SVA has broken out from 30 cents to 70 before the reports. There are strong opportunities for them in the coming year with potential deals with drugmakers and distributors.
biotechnology
BUY
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock probably has some legs. The Type 1 diabetes treatment they are working on is getting lots of attention. Trials continue to show results and they have raised money and signed agreements with large companies. It is a new biotech play and the potential market is very large. Unlock Premium - Try 5i Free
biotechnology
BUY
Credit card sized pouch inserted under the skin into which insulin cells are inserted. Control highs and lows of insulin. Also works with thyroid cells. Distribution platform for many drugs. Very positive. Revolutionary. His 12-month price target is $2.50-3, subject to outcome of trials.
biotechnology